• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BTG YOKNEAM Icepearl 2.1 CX L 90 Degree Needle; Unit, Cryosurgical, Accessories

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BTG YOKNEAM Icepearl 2.1 CX L 90 Degree Needle; Unit, Cryosurgical, Accessories Back to Search Results
Model Number FPRPR3617
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Cellulitis (1768)
Date of Event 11/30/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
B3: date of event- publish date selected detailed product information was not provided to bsc.Because the product lot number is unknown, we are unable to provide the complete unique identifier (udi) #.Harris, j., will, r., robinson, e., & finley, d.S.(2025).Rectal spacer gel displacement of the rectum during prostate cryoablation: a case series.Journal of urologic oncology, 23(3), 247-252.Https://doi.Org/10.22465/juo.255000900045.
 
Event or Problem Description
It was reported that cellulitis occurred, requiring intervention.The purpose of this article was to describe a novel case series using rectal spacer gel to displace and protect the rectum during prostate cancer cryoablation.Fifty men with clinically localized grade group 1-5 prostate cancer underwent concurrent rectal spacer gel and primary (n=27) or salvage (n=23) prostate cryoablation using the spaceoar hydrogel and icepearl (2.1 mm/14 gauge) and/or iceseed (1.5 mm/17 gauge) cryoablation needle(s).Of the 50 cases, there was only one case with a complication of perineal cellulitis, as a clavien-dindo grade ii complication.The cellulitis was able to be resolved with an incision and drainage of the fluid collection and antibiotics.There were no further complications observed.
 
Event or Problem Description
It was reported that cellulitis occurred, requiring intervention.The purpose of this article was to describe a novel case series using rectal spacer gel to displace and protect the rectum during prostate cancer cryoablation.Fifty men with clinically localized grade group 1-5 prostate cancer underwent concurrent rectal spacer gel and primary (n=27) or salvage (n=23) prostate cryoablation using the spaceoar hydrogel and icepearl (2.1 mm/14 gauge) and/or iceseed (1.5 mm/17 gauge) cryoablation needle(s).Of the 50 cases, there was only one case with a complication of perineal cellulitis, as a clavien-dindo grade ii complication.The cellulitis was able to be resolved with an incision and drainage of the fluid collection and antibiotics.There were no further complications observed.
 
Additional Manufacturer Narrative
B3: date of event- publish date selected.Detailed product information was not provided to bsc.Because the product lot number is unknown, we are unable to provide the complete unique identifier (udi) #.Harris, j., will, r., robinson, e., & finley, d.S.(2025).Rectal spacer gel displacement of the rectum during prostate cryoablation: a case series.Journal of urologic oncology, 23(3), 247-252.Https://doi.Org/10.22465/juo.255000900045.Investigation results: labeling review: review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review: a review of the cryoablation needle device confirmed that the reported event is a known event defined in the product's risk management documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
Icepearl 2.1 CX L 90 Degree Needle
Common Device Name
Unit, Cryosurgical, Accessories
Manufacturer (Section D)
BTG YOKNEAM
tavor building 1
po box 224
yokneam 20692 03
IS  2069203
Manufacturer (Section G)
Galil Medical Ltd.
tavor bldg. 1
industrial park
yokneam, 20692 03
IS   2069203
Manufacturer Contact
ricardo amaro castro
4100 hamline ave n
arden hills, MN 55112
+1(952)930-6396
MDR Report Key25896682
Report Number2124215-2026-39350
Device Sequence Number13297244
Product Code GEH
UDI-Device Identifier07290104831072
UDI-Public(01)07290104831072
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K162599
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Literature,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/01/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberFPRPR3617
Device Catalogue NumberFPRPR3617
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/24/2026
Supplement Date Received by Manufacturer08/03/2026
Initial Report FDA Received Date07/21/2026
Supplement Report FDA Received Date09/01/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-